Stock listing
NASDAQ:SCMP Sucampo Pharmaceuticals Inc Stock
Follow Sucampo Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SCMP
$18.00 USD
Close on Feb 13, 2018 · No longer trades
- Lowest – highest close
- $2.84 – $28.96 USDSince Aug 2, 2007 · lowest Dec 15, 2008 · highest Sep 17, 2015
Delisted NASDAQ:SCMP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SCMP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sucampo Pharmaceuticals Inc on 6ix
- Decks
- 77 decks · latest Nov 16, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (November 2017) | Investor day | 100 slides | Nov 16, 2017 |
| Q3 2017 Earnings Presentation | Earnings | 28 slides | Nov 1, 2017 |
| Cantor Fitzgerald Global Healthcare Conference 2017 | Conference | 22 slides | Sep 26, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 28 slides | Aug 2, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 24 slides | May 3, 2017 |
| Merger or Acquisition (April 2017) | Merger or acquisition | 15 slides | Apr 3, 2017 |
| 29th Annual ROTH Conference 2017 | Conference | 22 slides | Mar 13, 2017 |
| Q4 2016 Earnings Presentation | Earnings | 29 slides | Mar 8, 2017 |
| Corporate Update (January 2017) | Corporate update | 22 slides | Jan 9, 2017 |
| Debt Investor Presentation (December 2016) | Debt investors | 22 slides | Dec 19, 2016 |
Show 50 decks
This page holds 50 of 77 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Timothy P. Walbert Other companies: Latigo Biotherapeutics, Inc. (Chair, Board of Directors · Since at least Aug 6, 2026); Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Odyssey Therapeutics, Inc. (Director · Since at least May 7, 2026); BioMarin Pharmaceutical Inc. (Director · Since at least Feb 24, 2025); Sagimet Biosciences Inc. - Series A (Director · Since at least Apr 1, 2024); Mirum Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2023); Century Therapeutics, Inc. (Director · Since at least Oct 1, 2022); Aurinia Pharmaceuticals Inc (Director · Jan 1, 2021 – May 18, 2022 · Past); Assertio Holdings, Inc. (Director · May 20, 2020 – May 20, 2020 · Past); Exicure, Inc. (Director · Jul 22, 2019 – Jun 2, 2021 · Past); Egalet Corporation (Director · Mar 10, 2014 – May 20, 2020 · Past); Horizon Pharma PLC (Chairman, President and CEO, Director · Jul 28, 2011 – Mar 23, 2019 · Past); Raptor Pharmaceutical Corp (Director · Apr 11, 2011 – Mar 13, 2014 · Past); Idm Pharma Inc (President and CEO, Director · May 25, 2007 – Apr 3, 2008 · Past) | Director · Oct 12, 2015 – Feb 13, 2018 · Past |
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past) | Director · Jun 2, 2016 – Feb 13, 2018 · Past |
| Karen Smith Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | Director · Jul 15, 2017 – Feb 13, 2018 · Past |
| Paul Edick Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Oct 27, 2025); Xeris Biopharma Holdings, Inc. (See Remarks, Director · Oct 5, 2021 – Jan 31, 2024 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – Jun 5, 2020 · Past); PDL BioPharma Inc (Director · Sep 3, 2015 – Jun 8, 2018 · Past); Neos Therapeutics Inc (Director · Jul 22, 2015 – Jul 3, 2017 · Past); Durata Therapeutics Inc (Chief Executive Officer, Director · Mar 15, 2012 – Nov 17, 2014 · Past); Lumos Pharma Inc (Director · Nov 10, 2011 – May 12, 2017 · Past) | Director · Aug 1, 2016 – Feb 13, 2018 · Past |
| Robert J. Spiegel Other companies: Ernexa Therapeutics Inc. (Director · Since at least Sep 14, 2026); RenovoRx, Inc. (Director · Since at least Apr 25, 2023); Geron Corporation (Director · Since at least Sep 29, 2017); Athenex Inc (Director · Aug 4, 2020 – Apr 21, 2023 · Past); Ayala Pharmaceuticals Inc (Director · May 7, 2020 – Jan 19, 2023 · Past); Bio Green Med Solution, Inc. (Director · Sep 6, 2018 – Jun 30, 2023 · Past); PDS Biotechnology Corporation (Director · Jun 19, 2018 – Mar 15, 2019 · Past) | Director · Feb 13, 2018 – Feb 13, 2018 · Past |
| Cary Claiborne Other companies: Adial Pharmaceuticals, Inc (Chief Executive Officer, Director · Since at least Apr 7, 2026); NeuroSense Therapeutics Ltd. (Board Member · Since at least Mar 18, 2026); Azora Therapeutics, Inc. (Chief Executive Officer, Director · Since at least Nov 2, 2021); LadRx Corporation (Director · Jan 15, 2024 – Jan 15, 2024 · Past); New Generation Biofuels Holdings Inc (CEO, CFO and President, Director · Dec 1, 2008 – Dec 24, 2009 · Past); Osiris Therapeutics Inc (Chief Financial Officer · Aug 3, 2006 – Nov 23, 2007 · Past) | Chief Financial Officer · Oct 24, 2011 – Sep 11, 2014 · Past |
| Peter Greenleaf Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Antares Pharma Inc (Director · Dec 12, 2018 – May 24, 2022 · Past); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); BioDelivery Sciences International Inc (Director · May 21, 2018 – Mar 22, 2022 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past) | Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past |
| Timothy I Maudlin Other companies: E2open Parent Holdings Inc (Director · Since at least Feb 4, 2021); Pluralsight Inc (Director · May 17, 2018 – Apr 6, 2021 · Past); Alteryx Inc (Director · Mar 23, 2017 – Mar 19, 2024 · Past); ExactTarget Inc (Director · Mar 21, 2012 – Jul 11, 2013 · Past); MediaMind Technologies Inc (Director · Aug 10, 2010 – Aug 10, 2010 · Past); Web.com Group Inc (Director · Oct 30, 2008 – Oct 11, 2018 · Past) | Director · Aug 2, 2007 – May 15, 2013 · Past |
| Maureen O'Connell Other companies: Terex Corporation (Director · Since at least Feb 2, 2026); Rev Group Inc (Director · Since at least Aug 25, 2023); Acacia Research Corporation (Lead Independent Director · Since at least Jan 17, 2019); Harte Hanks, Inc. (Director · Jun 22, 2018 – Mar 21, 2020 · Past); Scholastic Corporation (EVP, CAO & CFO · Jan 22, 2007 – Sep 25, 2017 · Past) | Director · Feb 27, 2013 – Feb 13, 2018 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Immunomedics Inc (Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past) | CFO · Mar 20, 2017 – Feb 13, 2018 · Past |
All 33 people
| Person | Seat |
|---|---|
| Peter A Kiener Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Cue Biopharma, Inc. (Director · Since at least Dec 18, 2017); Palvella Therapeutics, Inc. (Director · Sep 7, 2018 – Jun 21, 2023 · Past); Medimmune Inc (SVP, Research · Feb 8, 2006 – Feb 23, 2006 · Past) | Chief Science Officer · Mar 4, 2015 – Feb 13, 2018 · Past |
| Thomas J Knapp Other companies: Ascentage Pharma Group International (SVP/General Counsel · Since at least Mar 18, 2026); Osiris Therapeutics Inc (Director · Feb 7, 2017 – Feb 7, 2017 · Past); SELLAS Life Sciences Group, Inc. (General Counsel · Jun 25, 2015 – Feb 6, 2017 · Past); Northwestern Corp (VP- General Counsel · Nov 1, 2006 – Nov 1, 2007 · Past) | Director · Mar 11, 2010 – May 2, 2011 · Past |
| Ronald W Kaiser Other companies: Vaccinogen Inc (Director · Feb 11, 2015 – Apr 20, 2015 · Past); Tangoe Inc (Director · Jul 26, 2011 – Jun 15, 2017 · Past); Vocus Inc (Director · Apr 5, 2006 – May 30, 2014 · Past) | CFO · Aug 2, 2007 – Dec 11, 2007 · Past |
| Andrew J Ferrara Other companies: Indevus Pharmaceuticals Inc (Director · Apr 10, 2006 – Feb 23, 2009 · Past); Mgi Pharma Inc (Director · Dec 30, 2005 – Jan 28, 2008 · Past) | Director · Jul 16, 2007 – May 2, 2011 · Past |
| V Sue Molina Other companies: Adeia Inc. (Director · Since at least Oct 1, 2022); Xperi Inc. (Director · Feb 7, 2018 – May 3, 2019 · Past) | Director · Aug 2, 2007 – Aug 2, 2007 · Past |
| Alex Driggs Other companies: Autolus Therapeutics plc (SVP, Legal Affairs and GC · Since at least Mar 18, 2026) | General Counsel & Corp. Sec. · Jun 1, 2017 – Feb 13, 2018 · Past |
| Barbara A Munder Other companies: PetSmart Inc (Director · Dec 30, 2005 – Mar 11, 2015 · Past) | Director · Feb 27, 2013 – May 29, 2015 · Past |
| Charles S Hrushka Other companies: Pernix Therapeutics Holdings Inc (VP of Sales and Marketing · Dec 5, 2011 – Jan 20, 2012 · Past) | VP Marketing · Aug 2, 2007 – Aug 2, 2007 · Past |
| Jason Patrick Meyenburg Other companies: Disc Medicine, Inc. (Chief Executive Officer, Director · Feb 5, 2021 – Jan 3, 2022 · Past) | Chief Commercial Officer · Jun 1, 2017 – Feb 13, 2018 · Past |
| Mariam E Morris Other companies: Avalo Therapeutics, Inc. (Chief Financial Officer · Oct 14, 2015 – Jan 22, 2018 · Past) | Chief Acctg. Officer, Treas. · Aug 2, 2007 – Dec 11, 2007 · Past |
| Matthew Maxwell Donley Other companies: Aurinia Pharmaceuticals Inc (Chief Operating Officer · Since at least Jan 1, 2021) | EVP, Global HR, IT & Strategy · Mar 4, 2015 – Feb 13, 2018 · Past |
| Matthias Alder Other companies: Gain Therapeutics, Inc. (Chief Executive Officer, Director · Dec 23, 2021 – Mar 26, 2024 · Past) | EVP, Gen. Council & Sec. · Mar 4, 2015 – Jun 30, 2017 · Past |
| Andrew P Smith | Chief Financial Officer · Jan 30, 2015 – Dec 31, 2016 · Past |
| Anthony C Celeste | Director · Oct 18, 2007 – Mar 11, 2015 · Past |
| Daniel P Getman | Director · Sep 1, 2011 – Nov 28, 2016 · Past |
| Gayle R Dolecek | Director · Aug 2, 2007 – Mar 18, 2014 · Past |
| Hidetoshi Mine | Director · Aug 2, 2007 – Dec 31, 2007 · Past |
| Jan Smilek | Chief Accounting Officer · Jun 5, 2008 – May 4, 2010 · Past |
| Jones W Bryan | Sr. Vice Pres., BD & Licensing · Dec 31, 2017 – Feb 13, 2018 · Past |
| Kei S Tolliver | Director · Aug 2, 2007 – May 29, 2015 · Past |
| Peter Lichtlen | Chief Medical Officer · Mar 4, 2015 – Feb 13, 2018 · Past |
| Ryuji Ueno | CEO, Chief Scientific Officer, Director · Aug 2, 2007 – Jan 17, 2014 · Past |
| Stanley G Miele | Chief Commercial Officer · Oct 10, 2008 – Jun 30, 2015 · Past |
Log in to ask 6ix AI your own questions about Sucampo Pharmaceuticals Inc.